Patricia S Andrews
CIK 1445710 · View on SEC EDGAR ↗
First SEC filing: Jan. 2, 2026 · Latest: Jan. 2, 2026
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Nov. 16, 2021 | CBIO | P | 40,000 | $2.05 | $82,000 | 45,250 Direct | +761.90% | Acquired | -92.1% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| May 1, 2024 | CBIO | Stock Option (right to buy) | Common Stock (40,000) | $1.62 | April 30, 2034 | 40,000 | Acquired |
| May 19, 2023 | CBIO | Stock Option (right to buy) | Common Stock (35,000) | $1.98 | May 18, 2033 | 35,000 | Acquired |
| May 18, 2022 | CBIO | Stock Option (right to buy) | Common Stock (21,000) | $0.60 | May 17, 2032 | 21,000 | Acquired |
| May 18, 2021 | CBIO | Stock Option (right to buy) | Common Stock (10,500) | $2.55 | May 17, 2031 | 10,500 | Acquired |
| May 22, 2020 | CBIO | Stock Option (right to buy) | Common Stock (21,000) | $3.00 | May 21, 2030 | 21,000 | Acquired |
| May 17, 2019 | CBIO | Stock Option (right to buy) | Common Stock (21,000) | $12.39 | May 16, 2029 | 21,000 | Acquired |
| May 18, 2018 | CBIO | Stock Option (right to buy) | Common Stock (11,000) | $18.41 | May 17, 2028 | 11,000 | Acquired |
| June 9, 2017 | CBIO | Stock Option (right to buy) | Common Stock (22,000) | $11.63 | June 9, 2027 | 22,000 | Acquired |
| Jan. 19, 2012 | INCY | Non-Qualified Stock Option (right to buy) | Common Stock (93,900) | $17.79 | Jan. 18, 2019 | 93,900 | Acquired |
| Jan. 19, 2012 | INCY | Incentive Stock Option (right to buy) | Common Stock (6,100) | $17.79 | Jan. 18, 2019 | 6,100 | Acquired |
| Jan. 25, 2011 | INCY | Non-Qualified Stock Option (right to buy) | Common Stock (95,257) | $14.72 | Jan. 24, 2018 | 95,257 | Acquired |
| Jan. 25, 2011 | INCY | Incentive Stock Option (right to buy) | Common Stock (4,743) | $14.72 | Jan. 24, 2018 | 4,743 | Acquired |
| May 21, 2010 | INCY | Incentive Stock Option (right to buy) | Common Stock (3,473) | $12.46 | May 20, 2017 | 3,473 | Acquired |
| May 21, 2010 | INCY | Non-Qualified Stock Option (right to buy) | Common Stock (21,527) | $12.46 | May 20, 2017 | 21,527 | Acquired |
| May 18, 2010 | INCY | Incentive Stock Option (right to buy) | Common Stock (417) | $13.34 | May 17, 2017 | 417 | Acquired |
| May 18, 2010 | INCY | Non-Qualified Stock Option (right to buy) | Common Stock (14,583) | $13.34 | May 17, 2017 | 14,583 | Acquired |
| Jan. 21, 2010 | INCY | Incentive Stock Option (right to buy) | Common Stock (12,070) | $9.41 | Jan. 20, 2017 | 12,070 | Acquired |
| Jan. 21, 2010 | INCY | Non-Qualified Stock Option (right to buy) | Common Stock (72,930) | $9.41 | Jan. 20, 2017 | 72,930 | Acquired |
| Jan. 27, 2009 | INCY | Non-Qualified Stock Option (right to buy) | Common Stock (97,220) | $3.11 | Jan. 26, 2016 | 97,220 | Acquired |
| Jan. 27, 2009 | INCY | Incentive Stock Option (right to buy) | Common Stock (2,780) | $3.11 | Jan. 26, 2016 | 2,780 | Acquired |
| Oct. 21, 2008 | INCY | Non-Qualified Stock Option (right to buy) | Common Stock (167,185) | $5.68 | Oct. 20, 2015 | 167,185 | Acquired |
| Oct. 21, 2008 | INCY | Incentive Stock Option (right to buy) | Common Stock (52,815) | $5.68 | Oct. 20, 2015 | 52,815 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 5 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Jan. 2, 2026 | ONCY | Common Shares | 42,728 | Direct |
| Jan. 2, 2026 | ONCY | Stock Option→ Common Shares (45,000) | 45,000 | Direct |
| Jan. 2, 2026 | ONCY | Stock Option→ Common Shares (120,000) | 120,000 | Direct |
| Jan. 2, 2026 | ONCY | Stock Option→ Common Shares (30,000) | 30,000 | Direct |
| June 12, 2017 | CBIO | No securities beneficially owned | 0 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2011 | $364,694 | — | — | $720,952 | $247,026 | — | $3,866 | $1,336,538 |
| 2010 | $353,234 | — | — | $637,574 | $219,632 | — | $3,834 | $1,214,274 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.